Discover real-world insights on overcoming biotech clinical trial design challenges.
Biotech startups often face challenges when designing their first clinical studies, facing regulatory hurdles and evolving industry standards. Making the right study design decisions early on is critical to avoid costly delays and missteps.
In this webinar, we welcome Marc Ceusters from Kaerus Bioscience, a biotech company that partnered with SGS to refine their study design. Alongside SGS's Thomas Lodeweyckx, Marc will walk through the thinking process behind key study design decisions – how challenges were assessed, regulatory feedback was integrated, and ultimately, how these insights shaped an optimized trial setup.
Rather than just discussing theory, this session provides a real-world approach to navigating clinical trial design with a structured and strategic mindset.
Agenda
- Why certain study designs are increasingly used
- What challenges arise when designing a study
- How regulatory feedback influences final decisions
- Lessons from a successfully designed and executed study
- Q&A session: engage with experts, clarify your concerns
The webinar is aimed at pharmaceutical and biotech professionals, as well as esteemed clinicians.
Presenters:
Thomas Lodeweyckx, Associate Medical Director, SGS
Marc Ceusters, Head Of Development, Kaerus Bioscience Ltd
This webinar takes place on Thursday, March 27, 2025, at 03:00 pm (CET).
